Arzoxifene - paediatric investigation plan

arzoxifene

Key facts

• Active substance:
  arzoxifene
• Therapeutic area:
  Oncology
• Decision number:
  P/29/2008
• PIP number:
  Arzoxifene
• Pharmaceutical form(s):
  Film-coated tablet
• Condition(s) / indication(s):
  • Breast carcinoma
  • Postmenopausal osteoporosis
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  23/05/2008
• Compliance check done:
  No

Decision

P/29/2008: European medicines agency decision of 23 May 2008 on the application for product specific waiver for arzoxifene (EMEA-000179-PIP01-07) in accordance with Regulation (EC) No 1901/2006 of the European Parliament...

Adopted Reference Number: EMEA/259255/2008